GENERAL
Amneal Pharma Completes Kashiv Bio Buy, Strengthens Biosimilars Platform
Amneal Pharmaceuticals Inc. has completed its acquisition of Kashiv BioSciences LLC, creating a fully integrated global biosimilars platform with capabilities spanning research, development, manufacturing and commercialisation. The acquisition brings together Kashiv’s biologics research, development and manufacturing capabilities with Amneal’s commercial scale, positioning biosimilars as a major long-term growth pillar for the company’s affordable medicines business. […]
CW Bureau
·
Aug 11, 2026
GENERAL
Kwality Pharma Ups FY27 Guidance, Targets ₹1,000 Cr Revenue By FY29
Kwality Pharmaceutical Ltd, which has doubled its turnover to ₹500 crore in three years, has raised its FY27 revenue guidance to over ₹700 crore from ₹650 crore and is targeting more than ₹1,000 crore by FY29. “Over the longer term, we continue to work toward doubling revenue over the next three years, with a goal […]
CW Bureau
·
Aug 10, 2026
HOSPITALITY
Rubicon Research To Buy 85% Stake In Arinna Lifesciences For ₹175.92 Cr
Rubicon Research Ltd has entered into definitive agreements to acquire an 85% stake in Arinna Lifesciences Ltd for a consideration of ₹175.92 crore, marking a strategic expansion in the domestic formulations market. The transaction, which values Arinna at an enterprise value of ₹200 crore on a cash and debt-free basis, is expected to be concluded […]
CW Bureau
·
Apr 15, 2026
